Document is current
Any future updates will be listed below
-
Authors
Pu, Zhixin
Wang, Peiwen
Wang, Mengyao
Chen, Yaxin
Zhu, Yating
Jiao, Yuan
Zou, Weiwei
Yu, Biao
Cheng, Huiru
Liu, Yajing
Cao, Yunxia
Ji, Dongmei
Liang, Dan https://orcid.org/0000-0003-2404-3075
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2024YFC2707200)
Dan Liang (XJ2020025)
the Anhui Institute of Translational Medicine (2023zhyx-B01)
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 8 September 2025
First Online: 10 October 2025
Declarations
:
: The human samples were provided by the First Affiliated Hospital of Anhui Medical University (Anhui, China),and all teratoma experiments were approved by the Biomedical Ethics Committee of the First Affiliated Hospital of Anhui Medical University on January 6, 2022 (Approval No. PJ20220128). The title of the approved project is “In vitro reprogramming of peripheral blood mononuclear cells from patients with mitochondrial diseases,” and the donor has signed written informed consent.
: Not applicable.
: All the authors declare no competing interests.
